Orlando Penaloza
Internal Medicine · Allentown, PANPI 1083881585
Payments from drug & device makers
Across 309 payments — averaging $502.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$103K
- Gilead$50K
- Novo Nordisk$676
- Boehringer Ingelheim$354
- Lilly USA, LLC$351
- Abbott$165
- plus $653 from 16 others
What the payments were for
- Consulting fees$7,2255%
- Speaking & faculty fees$125,00581%
- Travel & lodging$14,78110%
- Food & beverage$8,1035%
- Education$1420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 121 | $102,922 |
| Gilead | 79 | $50,134 |
| Novo Nordisk | 32 | $676 |
| Boehringer Ingelheim | 15 | $354 |
| Lilly USA, LLC | 22 | $351 |
| Abbott | 5 | $165 |
| AstraZeneca | 8 | $129 |
| Johnson & Johnson | 6 | $109 |
| Sanofi-aventis U.S. LLC | 5 | $94 |
| Xeris Pharmaceuticals, Inc. | 3 | $46 |
| Medtronic(2 entities) | 2 | $42 |
| Amgen | 1 | $32 |
| Esperion Therapeutics, Inc. | 1 | $29 |
| BD | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Valeritas, Inc. | 1 | $23 |
| Merck | 1 | $20 |
| Viiv Healthcare Company | 1 | $19 |
| Mannkind Corporation | 1 | $18 |
| Bayer | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$155,256 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 146 | $176,671 |
| TrulicityDulaglutide | 48 | $59,818 |
| EliquisApixaban | 32 | $39,765 |
| OzempicSemaglutide | 22 | $32,606 |
| FarxigaDapagliflozin Propanediol | 29 | $31,941 |
| JanumetSitagliptin Phos/Metformin Hcl | 32 | $28,165 |
| TradjentaLinagliptin | 30 | $19,959 |
| Advair HfaFluticasone Propion/Salmeterol | 30 | $18,124 |
| LinzessLinaclotide | 16 | $15,419 |
| VemlidyTenofovir Alafenamide | 11 | $14,841 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $14,417 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 16 | $13,314 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $11,997 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $7,863 |
| JentaduetoLinagliptin/Metformin Hcl | 11 | $7,747 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Jentadueto | $354 | $204,377187 claims |
| Lilly USA, LLCTrulicity | $351 | $59,81848 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $129 | $39,80442 claims |
| Novo NordiskOzempic | $676 | $32,60622 claims |
| MerckJanumet | $20 | $28,16532 claims |
| AbbVieLinzess | $102,922 | $15,41916 claims |
| GileadVemlidy | $50,134 | $14,84111 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $94 | $13,31416 claims |
| GSKIncruse Ellipta | $13 | $3,97612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Allentown
- Joseph YozviakAllentown$1.1M
- Eric MuellerAllentown$585K
- Jonathan EpsteinPhiladelphia$13.1M
- Siddharth ShethPittsburgh$11M
- Nathan PatelTannersville$9.5M
- Pitamber DevgonPhiladelphia$7.5M
- Christopher StillDanville$7.1M
- Liza VillaruzPittsburgh$6.6M
- Paul HartleyUniontown$4.9M
- Victor KoladeSayre$4.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.